Partnership Requests for Gilead Sciences
WEBCollaboration plays a critical role in our mission to achieve a healthier world for all people. We place high value on partnerships with companies, organizations and communities whose strengths complement and augment our own as we collectively work to achieve scientific breakthroughs and improve access to care for those who need it most. Over ...
Gilead and Assembly Biosciences Establish Partnership to …
WEBOct 17, 2023 · ––Partnership combines Gilead’s proven track record and mission to develop transformative therapeutics targeting serious viral diseases, with Assembly Bio’s expertise and focus on antiviral R&D to advance differentiated treatments for herpesviruses, HBV, HDV and beyond—
Gilead Sciences and Arcus Biosciences Expand Partnership to …
WEBMay 15, 2023 · Under the terms of the expanded collaboration, Arcus will receive an upfront payment of $35 million and will initiate research programs against up to four targets jointly selected by the parties that are applicable to inflammatory diseases.
Partnerships and Community - Gilead
WEBGilead has been recognised as one of the best industry partners in the UK and Ireland. We work closely with patients and patient groups to understand their experiences, advocate for their priorities and enable their voices to be heard.
Gilead Sciences Global Access Partnerships
WEBAccess Partnerships. We work with a network of regional distributors to enable greater access to our portfolio of medicines in low- and middle-income countries. We also work with voluntary licensees, the Medicines Patent Pool and other stakeholders to expand access to our medicines around the world.
Partnerships and Community - Gilead
WEBGilead Canada is committed to collaborative partnerships with governments, community, academia and healthcare providers to address Canada’s biggest health challenges. GLOW Indigenous Health Grant At Gilead Sciences Canada, we recognize the health inequalities faced by Indigenous communities, often characterized by higher rates of HIV and ...
Gilead Sciences and Arcus Biosciences Expand Partnership to …
WEBMay 15, 2023 · Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation. – Gilead to Have Early Option to Exclusively License Drug Candidates Against up to Four Targets for Inflammatory Diseases –. – Expanded Research Collaboration May Result in up to $1 Billion in Option Fees and Milestone Payments by Gilead ...
Gilead draws up $20M pact with cancer biotech Cartography
WEBMay 28, 2024 · Gilead Sciences is drawing up $20 million cash to partner with Cartography Biosciences and navigate drug discovery for triple-negative breast cancer and adenocarcinoma, a common form of...
Gilead and MacroGenics Announce Oncology ... - Gilead Sciences
WEBOct 17, 2022 · The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with …
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% ... - BioSpace
WEBJun 20, 2024 · Gilead Sciences, Inc. announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, demonstrated 100% efficacy for the investigational use of HIV prevention in cisgender women. ... Through partnerships, collaborations and ...